Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF
This article or press release has no online content. Please download the associated documents for more information.
Attachment
14 October 2024
1 mins read
Excellence in action: Ipsen is first pharma company to receive two Gold Shingo Prizes
29 June 2022
1 mins read
Ipsen announces U.S. FDA Priority Review for palovarotene New Drug Application in patients with fibrodysplasia ossificans progressiva following resubmission
01 June 2021
1 mins read
Ipsen announces the launch of an Employee Shareholding Plan